Literature DB >> 19528139

Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women.

Toshihiro Tanaka1, Ken Nakajima, Atsuko Murashima, Facundo Garcia-Bournissen, Gideon Koren, Shinya Ito.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19528139      PMCID： PMC2704420          DOI： 10.1503/cmaj.090866

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  20 in total

1.  Deaths from Asian influenza associated with pregnancy.

Authors:  D W FREEMAN; A BARNO
Journal:  Am J Obstet Gynecol       Date:  1959-12       Impact factor: 8.661

2.  Maternal influenza during pregnancy and risk of congenital abnormalities in offspring.

Authors:  Nándor Acs; Ferenc Bánhidy; Erzsébet Puhó; Andrew E Czeizel
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2005-12

Review 3.  Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802.

Authors:  G He; J Massarella; P Ward
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

4.  Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers.

Authors:  L M Cass; C Efthymiopoulos; A Bye
Journal:  Clin Pharmacokinet       Date:  1999       Impact factor: 6.447

Review 5.  Neuraminidase inhibitors for preventing and treating influenza in healthy adults.

Authors:  T O Jefferson; V Demicheli; C Di Pietrantonj; M Jones; D Rivetti
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

Review 6.  Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis.

Authors:  Myla E Moretti; Benjamin Bar-Oz; Shawn Fried; Gideon Koren
Journal:  Epidemiology       Date:  2005-03       Impact factor: 4.822

Review 7.  Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.

Authors:  Penelope Ward; Ian Small; James Smith; Pia Suter; Regina Dutkowski
Journal:  J Antimicrob Chemother       Date:  2005-02       Impact factor: 5.790

8.  ACOG committee opinion number 305, November 2004. Influenza vaccination and treatment during pregnancy.

Authors: 
Journal:  Obstet Gynecol       Date:  2004-11       Impact factor: 7.661

Review 9.  Zanamivir: a review of clinical safety.

Authors:  B Freund; S Gravenstein; M Elliott; I Miller
Journal:  Drug Saf       Date:  1999-10       Impact factor: 5.606

10.  Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-05-22       Impact factor: 17.586
View more
  31 in total

Review 1.  Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.

Authors:  Nicolas Widmer; Pascal Meylan; Anton Ivanyuk; Manel Aouri; Laurent A Decosterd; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2010-11       Impact factor: 6.447

2.  Pharmacokinetics of oseltamivir among pregnant and nonpregnant women.

Authors:  Richard H Beigi; Kelong Han; Raman Venkataramanan; Gary D Hankins; Shannon Clark; Mary F Hebert; Thomas Easterling; Anne Zajicek; Zhaoxia Ren; Donald R Mattison; Steve N Caritis
Journal:  Am J Obstet Gynecol       Date:  2011-03-09       Impact factor: 8.661

3.  [Use of antivirals in influenza pandemics].

Authors:  Eduard Diogène Fadini; Dolores Rodríguez Cumplido; Montserrat Bosch Ferrer
Journal:  Aten Primaria       Date:  2009-11-25       Impact factor: 1.137

4.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Authors:  Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

5.  Novel Influenza A (H1N1) Viral Infection in Late Pregnancy: Report of a Case.

Authors:  Brad J Hymel; James H Diaz; Carmen L Labrie-Brown; Alan D Kaye
Journal:  Ochsner J       Date:  2010

6.  STATEMENT ON PREGNANCY AND TRAVEL: Committee to Advise on Tropical Medicine and Travel.

Authors:  C Beallor
Journal:  Can Commun Dis Rep       Date:  2010-03-08

Review 7.  Clinical use of approved influenza antivirals: therapy and prophylaxis.

Authors:  Michael G Ison
Journal:  Influenza Other Respir Viruses       Date:  2013-01       Impact factor: 4.380

Review 8.  2009 H1N1 influenza.

Authors:  Seth J Sullivan; Robert M Jacobson; Walter R Dowdle; Gregory A Poland
Journal:  Mayo Clin Proc       Date:  2009-12-10       Impact factor: 7.616

9.  The use of antiviral drugs for influenza: Guidance for practitioners 2012/2013.

Authors:  Fred Y Aoki; Upton D Allen; H Grant Stiver; Gerald A Evans
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

Review 10.  Guidelines on management of human infection with the novel virus influenza A (H1N1)--a report from the Hospital das Clínicas of the University of São Paulo.

Authors:  Ludhmila Abrahao Hajjar; Denise Schout; Filomena Regina Barbosa Gomes Galas; David Everson Uip; Anna Sara Shafferman Levin; Helio Hehl Caiaffa Filho; Pedro Takanori Sakane; Carlos Alberto Suslik; Jose Manoel de Camargo Teixeira; Eloisa Bonfa; Antonio Alci Barone; Milton de Arruda Martins; Marcos Boulos; Jose Otavio Costa Auler
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.